National Health Investors, Inc.
NHI
$74.63
-$0.27-0.36%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.61% | 5.66% | 6.00% | 6.90% | 7.16% |
| Total Other Revenue | 61.26% | 37.13% | 16.20% | 8.24% | 8.60% |
| Total Revenue | 17.78% | 13.02% | 8.40% | 7.21% | 7.49% |
| Cost of Revenue | 60.78% | 30.85% | 329.53% | 307.49% | 2,032.45% |
| Gross Profit | 9.67% | 9.61% | -5.33% | -5.17% | -8.85% |
| SG&A Expenses | 21.79% | 35.53% | 31.95% | 28.70% | 21.32% |
| Depreciation & Amortization | 16.94% | 13.30% | 11.59% | 8.48% | 4.63% |
| Other Operating Expenses | 108.11% | 2,818.92% | -97.85% | -98.25% | -99.00% |
| Total Operating Expenses | 33.70% | 23.72% | 14.38% | 9.01% | 7.49% |
| Operating Income | 5.10% | 4.67% | 3.77% | 5.83% | 7.48% |
| Income Before Tax | 4.95% | 3.04% | 16.09% | 12.01% | 6.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.95% | 3.04% | 16.09% | 12.01% | 6.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -0.93% | 3.19% | 21.82% | 13.37% | 11.33% |
| Net Income | 4.89% | 3.04% | 16.14% | 12.02% | 6.88% |
| EBIT | 5.10% | 4.67% | 3.77% | 5.83% | 7.48% |
| EBITDA | 8.37% | 7.04% | 5.91% | 6.55% | 6.68% |
| EPS Basic | -1.91% | -3.48% | 9.20% | 7.24% | 4.22% |
| Normalized Basic EPS | 0.44% | 0.56% | -0.91% | 2.91% | 7.95% |
| EPS Diluted | -1.72% | -3.33% | 9.11% | 6.79% | 3.71% |
| Normalized Diluted EPS | 0.68% | 0.77% | -0.93% | 2.40% | 7.27% |
| Average Basic Shares Outstanding | 6.97% | 6.91% | 6.51% | 4.29% | 2.39% |
| Average Diluted Shares Outstanding | 6.72% | 6.69% | 6.54% | 4.81% | 3.04% |
| Dividend Per Share | 1.67% | 1.11% | 0.56% | 0.00% | 0.00% |
| Payout Ratio | 0.04% | 0.05% | -0.09% | -0.08% | -0.05% |